0000939767-22-000100.txt : 20220812 0000939767-22-000100.hdr.sgml : 20220812 20220812202326 ACCESSION NUMBER: 0000939767-22-000100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220811 FILED AS OF DATE: 20220812 DATE AS OF CHANGE: 20220812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Senner Christopher J. CENTRAL INDEX KEY: 0001648367 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 221161964 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_166035018251392.xml FORM 4 X0306 4 2022-08-11 0 0000939767 EXELIXIS, INC. EXEL 0001648367 Senner Christopher J. C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 0 1 0 0 EVP and CFO Common Stock 2022-08-11 4 M 0 225000 6.21 A 670882 D Common Stock 2022-08-11 4 F 0 152867 19.23 D 518015 D Common Stock 2723 I By 401(k) Option (right to buy) 6.21 2022-08-11 4 M 0 225000 0 D 2016-09-16 2022-09-15 Common Stock 225000.0 0 D Includes 166,412 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Represents a "net exercise" of an outstanding stock option. The Reporting Person received 225,000 shares of Common Stock on the net exercise of a stock option to purchase 72,133 shares of Common Stock. The Issuer withheld 152,867 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing price of Common Stock on August 11, 2022 of $19.23. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 11, 2022. The option, representing the right to purchase a total of 225,000 shares of Common Stock, became fully exercisable on September 16, 2019. /s/ Nina Ayer, Attorney in Fact 2022-08-12